Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients
Status:
Completed
Trial end date:
2017-08-15
Target enrollment:
Participant gender:
Summary
A prospective, randomized, controlled study to explore the efficacy and safety of using
either corifollitropin alfa 150 mcg or daily recombinant follicle stimulation hormone (FSH)
300 international unit (IU) for the stimulation treatment of subjects undergoing controlled
ovarian stimulation prior to IVF.
The study is designed as a non-inferiority trial. The sample size for this trial of 400
subjects, in both groups, being treated for one IVF cycle is based upon the primary endpoint
of the number of oocytes retrieved.